G9034 is a valid 2023 HCPCS Code that could be used to indicate Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project) for reimbursement purposes.
G9034 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2020.
Zanamivir, inh pwdr, brand
G9034 code information
| HCPCS code: | G9034 |
| Description: | ZANAMIVIR, INHALATION POWDER, ADMINISTERED THROUGH INHALER, BRAND, PER 10 MG (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT) |
| Effective Date: | Jan 01, 2020 |
| Added Date: | Dec 01, 2004 |
| Termination Date: | HCPCS G9034 was terminated on Dec 31, 2019 |
| Pricing indicator: | 00 - SERVICE NOT SEPARATELY PRICED BY PART B (E.G., SERVICES NOT COVERED, BUNDLED, USED BY PART A ONLY, ETC.) PHYSICIAN FEE SCHEDULE AND NON-PHYSICIAN PRACTITIONERS |
| Multi Pricing indicator: | 9 - NOT APPLICABLE AS HCPCS NOT PRICED SEPARATELY BY PART B (PRICING INDICATOR IS 00) OR VALUE IS NOT ESTABLISHED (PRICING INDICATOR IS ´99´) |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to G9034